First patients take new pill aimed at starving cancer cells
Disease control
Recruiting now
This is the first study in people testing a new oral medication called TRE-515 for advanced solid tumors that have stopped responding to standard treatments. The main goal is to find the highest safe daily dose and understand how the drug moves through the body. Researchers will …
Phase: PHASE1 • Sponsor: Trethera • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC